Overview

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of Duloxetine vs. placebo on pain as determined by change in the Brief Pain Inventory (BPI) from baseline over 8 weeks of treatment
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride